journal article·2026-01Open access

Multiwalled Carbon Nanotubes as Physical Drivers of Chromosome Instability and Inflammatory Responses

Núria Pulido‐Artola, Joan Repullés, Marina Rodriguez‐Muñoz, Teresa Anglada, Anna Genescà

Small Structures· Volume 7· Issue 1

Abstract

Multiwalled carbon nanotubes (MWCNTs) are widely used in industry; however, exposure to these fiber‐like structures has been associated with acute and chronic toxicological effects. Upon inhalation, human epithelial cells internalize MWCNTs by macropinocytosis. Once internalized, MWCNTs have been associated with mesothelioma and inflammation pathologies, similar to those induced by asbestos. While most previous studies have emphasized the chemical properties of MWNCTs as drivers of toxicity, this article highlights their fibrous morphology as a key factor in their genotoxic potential. Exposure of retinal pigmental epithelial cells to NM‐401 MWCNT significantly increased the frequencies of lagging chromosomes, micronuclei, and binucleated cells. Combined with time‐lapse imaging, these findings revealed a mechanically driven process in which MWCNTs physically obstruct chromosome migration and impair the final stage of cytokinesis in epithelial cells. Such mechanical disruptions cause aberrant mitotic outcomes, a well‐established source of chromosomal instability, and precursors of carcinogenesis. Moreover, MWCNTs induce cytoplasmic DNA mislocalization, which is sensed by cGAS and potentially triggers an innate immune response in epithelial cells. Consistently, continuous fiber exposure upregulates type I interferon‐related genes and pro‐inflammatory cytokines in both macrophages and epithelial cells. Altogether, these findings indicate that the genotoxic effects of NM‐401 MWCNTs contribute to the chronic inflammation observed in MWCNT‐induced pulmonary fibrosis.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications · Carbon Nanotubes in Composites

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Cell Biology, Physiology and Immunology Universitat Autònoma de Barcelona Bellaterra Spain

Unitat mixta d’investigació IRTA‐UAB en Sanitat Animal Centre de Recerca en Sanitat Animal (CReSA) Campus de la Universitat Autònoma de Barcelona (UAB) Catalonia Spain

IRTA Animal Health Centre de Recerca en Sanitat Animal (CReSA) Campus de la Universitat Autònoma de Barcelona (UAB) Catalonia Spain

Department of Experimental Oncology at IEO European Institute of Oncology IRCCS Milano Italy

Funding

Departament de Salut, Generalitat de Catalunya · Consejo de Seguridad Nuclear

References (70)

Show source-provided references
1. 10.2217/nnm.09.2510.2217/nnm.09.25 ↗
2. Orsi M. · 2020
3. 10.1016/j.taap.2005.01.00810.1016/j.taap.2005.01.008 ↗
4. Bergamaschi E. · 2021
5. 10.1007/s42823‐019‐00081‐510.1007/s42823‐019‐00081‐5 ↗
6. 10.1038/nnano.2009.30510.1038/nnano.2009.305 ↗
7. 10.1002/tox.2027010.1002/tox.20270 ↗
8. 10.1002/anie.20050338910.1002/anie.200503389 ↗
9. 10.1038/nnano.2006.20910.1038/nnano.2006.209 ↗
10. 10.1021/nl902647x10.1021/nl902647x ↗
11. 10.1002/smll.20100126010.1002/smll.201001260 ↗
12. Caoduro C. · 2017
13. 10.1155/2015/79318610.1155/2015/793186 ↗
14. 10.1016/j.taap.2018.06.02710.1016/j.taap.2018.06.027 ↗
15. 10.1021/nn200595c10.1021/nn200595c ↗
16. 10.3390/nano1210170810.3390/nano12101708 ↗
17. 10.1111/j.1349‐7006.2012.02318.x10.1111/j.1349‐7006.2012.02318.x ↗
18. 10.2131/jts.34.6510.2131/jts.34.65 ↗
19. 10.1111/cas.1243710.1111/cas.12437 ↗
20. International Agency for Research on Cancer Some Nanomaterials and Some Fibres IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Vol.111(2018).
21. 10.1021/acs.chemrestox.8b0006710.1021/acs.chemrestox.8b00067 ↗
22. 10.1080/17435390.2019.165192010.1080/17435390.2019.1651920 ↗
23. 10.1186/s12989‐016‐0158‐010.1186/s12989‐016‐0158‐0 ↗
24. van Zandwijk N. · 2020
25. 10.1016/j.toxlet.2016.09.01610.1016/j.toxlet.2016.09.016 ↗
26. 10.1539/joh.L915010.1539/joh.L9150 ↗
27. 10.1016/j.ecoenv.2015.03.00510.1016/j.ecoenv.2015.03.005 ↗
28. 10.1021/es702971g10.1021/es702971g ↗
29. 10.1016/j.chemosphere.2016.03.09910.1016/j.chemosphere.2016.03.099 ↗
30. 10.1186/1743‐8977‐11‐610.1186/1743‐8977‐11‐6 ↗
31. 10.1186/s12989‐019‐0318‐010.1186/s12989‐019‐0318‐0 ↗
32. 10.1021/nn302222m10.1021/nn302222m ↗
33. 10.1016/j.taap.2016.02.01610.1016/j.taap.2016.02.016 ↗
34. 10.1293/tox.2019‐007510.1293/tox.2019‐0075 ↗
35. 10.3109/17435390.2012.71964910.3109/17435390.2012.719649 ↗
36. Duke K. S. · 2018
37. 10.1080/10408444.2017.136775510.1080/10408444.2017.1367755 ↗
38. 10.3389/fimmu.2020.55261310.3389/fimmu.2020.552613 ↗
39. K. A.Jensen Y.Kembouche E.Christiansen et al. “NANOGENOTOX. Final Protocol for Producing Suitable Manufactured Nanomaterial Exposure Media 2011. [Online]. Available: Available at:www.nanogenotox.eu.
40. 10.1016/j.bbamem.2015.05.02410.1016/j.bbamem.2015.05.024 ↗
41. 10.1038/nmeth.122010.1038/nmeth.1220 ↗
42. Kay R. R. · 2021
43. 10.1539/joh.16‐0099‐OA10.1539/joh.16‐0099‐OA ↗
44. Siri S. O. · 2021
45. 10.3389/fcell.2023.121098310.3389/fcell.2023.1210983 ↗
46. 10.1091/mbc.E16‐03‐015910.1091/mbc.E16‐03‐0159 ↗
47. 10.1182/blood-2006-08-04033710.1182/blood-2006-08-040337 ↗
48. Dimitrov G. · 2024
49. Zhang M. · 2025
50. Rodriguez‐Muñoz M. · 2022
51. Ma R. · 2020
52. 10.1002/jbm.a.3606310.1002/jbm.a.36063 ↗
53. 10.1021/tx800101p10.1021/tx800101p ↗
54. Klaasen S. J. · 2022
55. 10.1016/j.mrgentox.2011.11.01710.1016/j.mrgentox.2011.11.017 ↗
56. 10.1042/BST038169110.1042/BST0381691 ↗
57. 10.1016/j.gde.2007.02.01110.1016/j.gde.2007.02.011 ↗
58. 10.1016/S0013‐9351(86)80069‐X10.1016/S0013‐9351(86)80069‐X ↗
59. 10.1016/S0002-9440(10)63147-110.1016/S0002-9440(10)63147-1 ↗
60. 10.1186/s13287-022-02847-710.1186/s13287-022-02847-7 ↗
61. 10.3390/cells1002033910.3390/cells10020339 ↗
62. 10.1016/j.addr.2013.07.01410.1016/j.addr.2013.07.014 ↗
63. 10.1016/j.jhazmat.2021.12598410.1016/j.jhazmat.2021.125984 ↗
64. 10.1038/s41577‐021‐00524‐z10.1038/s41577‐021‐00524‐z ↗
65. 10.3389/fimmu.2023.127324810.3389/fimmu.2023.1273248 ↗
66. 10.1038/nmeth.201910.1038/nmeth.2019 ↗
67. 10.1002/mrd.2248910.1002/mrd.22489 ↗
68. 10.1023/B:VISI.0000029664.99615.9410.1023/B:VISI.0000029664.99615.94 ↗
69. 10.1038/s41598‐019‐50035‐010.1038/s41598‐019‐50035‐0 ↗
70. 10.1093/clinchem/hvaf04310.1093/clinchem/hvaf043 ↗